根本沒用到實驗室
就網路上各家的研究報告,拿來統整一下
也不管各家研究背景相差多少,就一起表列出來
看起來就是高級一點的專題報告的感覺..
高端的資料文中寫道引用自文獻21
下方的文獻卻是列在20
20. MVC‐COV1901 VACCINE PROFILE. Available online: https://cdn.who.int/media/docs/default‐source/blue‐print/developer_medigen_allen‐lien.pdf (accessed on 23 May 2022).
這就是高端的簡報檔,共5頁. 根本沒提到效果%數
Immune Response to SARS‐CoV‐2 Vaccines
Navya Bellamkonda 1,†, Upendra Pradeep Lambe 2,†, Sonali Sawant 2, Shyam Sundar Nandi 2,*,
Chiranjib Chakraborty 3 and Deepak Shukla 4,*
1 Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago,
Chicago, IL 60612, USA; navyab3@uic.edu
2 ICMR‐NIV, Mumbai Unit, A. D. Road, Parel, Mumbai 400012, India; upendralambe69@gmail.com (U.P.L.);
ercintsonali@gmail.com (S.S.)
3 School of Life Science and Biotechnology, Adamas University, Kolkata 700126, India;
drchiranjib@yahoo.com
4 Department of Microbiology and Immunology, University of Illinois at Chicago, Chicago, IL 60612, USA
* Correspondence: nandibiotech@gmail.com (S.S.N.); dshukla@uic.edu (D.S.)
6個作者在二個國家的4各不同單位(第一個單位還是眼科..傻眼)
真實情況不知
樓上所猜測,疫情下遠距教學的共同編輯結果,不無可能
內文搜尋
從 APP 打開
X